PetIQ Inc (PETQ)
30.98
0.00 (0.00%)
USD |
NASDAQ |
Oct 25, 16:00
PetIQ Revenue (Quarterly): 328.94M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 328.94M |
| March 31, 2024 | 308.44M |
| December 31, 2023 | 219.93M |
| September 30, 2023 | 277.02M |
| June 30, 2023 | 314.55M |
| March 31, 2023 | 290.47M |
| December 31, 2022 | 184.08M |
| September 30, 2022 | 209.72M |
| June 30, 2022 | 252.01M |
| March 31, 2022 | 275.70M |
| December 31, 2021 | 196.64M |
| September 30, 2021 | 210.53M |
| June 30, 2021 | 271.01M |
| March 31, 2021 | 254.35M |
| December 31, 2020 | 164.21M |
| September 30, 2020 | 162.08M |
| June 30, 2020 | 266.98M |
| Date | Value |
|---|---|
| March 31, 2020 | 186.78M |
| December 31, 2019 | 154.34M |
| September 30, 2019 | 186.02M |
| June 30, 2019 | 220.63M |
| March 31, 2019 | 148.44M |
| December 31, 2018 | 111.02M |
| September 30, 2018 | 131.38M |
| June 30, 2018 | 171.14M |
| March 31, 2018 | 115.07M |
| December 31, 2017 | 51.93M |
| September 30, 2017 | 60.55M |
| June 30, 2017 | 87.18M |
| March 31, 2017 | 67.03M |
| December 31, 2016 | 44.91M |
| September 30, 2016 | 41.67M |
| June 30, 2016 | 61.28M |
| March 31, 2016 | 52.30M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
154.34M
Minimum
Dec 2019
328.94M
Maximum
Jun 2024
238.30M
Average
252.01M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| Omeros Corp | -- |
| BioCardia Inc | 0.003M |
| Revance Therapeutics Inc | 65.39M |
| Zevra Therapeutics Inc | 4.449M |
| Alector Inc | 15.08M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.32M |
| Total Expenses (Quarterly) | 300.74M |
| EPS Diluted (Quarterly) | 0.49 |
| Gross Profit Margin (Quarterly) | 26.84% |
| Profit Margin (Quarterly) | 4.66% |